Skip to main content
Retour
RAPT logo

RAPT Therapeutics, Inc.

Qualité des données : 100%
Suracheté
RAPT
NASDAQ Healthcare Biotechnology
58,01 €
0,00 € (0,00%)
Cap. Boursière : 959,26M
Fourchette du Jour
58,01 € 58,01 €
Fourchette 52 Semaines
5,67 € 58,02 €
Volume
10 846 697
Moyenne 50J / 200J
49,05 € / 26,91 €
Clôture Précédente
58,01 €

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Healthcare (626 pairs)

Métrique Action Médiane du Secteur
P/E -7,4 0,4
P/B 5,1 2,9
ROE % -77,1 3,8
Net Margin % 3,9
Rev Growth 5Y % 10,0
D/E 0,0 0,2

Points Clés

Debt/Equity of 0,02 — conservative balance sheet
Negative free cash flow of -83,42M

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
-77,09%
ROIC-52,51%
Net MarginN/A
Op. MarginN/A

Sécurité

Debt / Equity
0,02
Current Ratio4,87
Interest Coverage0,00

Valorisation

P/E Ratio
-7,39
P/B Ratio5,05
EV/EBITDAN/A
Dividend Yield0,00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 0,0 Net Income (TTM) -129,87M
ROE -77,09% ROA -54,04%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -83,42M
ROIC -52,51% FCF Growth (3Y) N/A
Safety
Debt / Equity 0,02 Current Ratio 4,87
Interest Coverage 0,00 Dividend Yield 0,00%
Valuation
P/E Ratio -7,39 P/B Ratio 5,05
P/S Ratio N/A PEG Ratio -0,11
EV/EBITDA N/A Dividend Yield 0,00%
Market Cap 959,26M Enterprise Value 794,01M

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Revenue 0,0 0,0 1,53M 3,81M 5,04M
Net Income -129,87M -116,80M -83,84M -69,20M -52,89M
EPS (Diluted) -25,49 -24,37 -20,61 -20,21 -17,53
Gross Profit 0,0 0,0 1,53M 3,81M 5,04M
Operating Income -136,10M -127,06M -85,80M -69,21M -53,21M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Total Assets 240,33M 173,33M 266,21M 198,64M 118,97M
Total Liabilities 50,42M 26,29M 21,04M 12,26M 14,79M
Shareholders' Equity 189,90M 147,04M 245,17M 186,38M 104,18M
Total Debt 4,49M 6,91M 8,99M 0,0 0,0
Cash & Equivalents 169,74M 47,48M 38,95M 24,03M 24,92M
Current Assets 235,24M 161,78M 252,69M 192,97M 115,60M
Current Liabilities 48,35M 21,84M 14,22M 9,60M 11,74M